Pain affects the quality of life of neuropathic patients

Neurological Sciences

Volumn 27, Issue 3, 2006, Pages 155-160

  Cocito, D ^a,c   Paolasso, I ^a   Pazzaglia, C ^b,e   Tavella, A ^a   Poglio, F ^a   Ciaramitaro, P ^d   Scarmozzino, A ^f   Cossa, F M ^c   Bergamasco, B ^a,c   Padua, L ^b,e  

^a UNIVERSITY OF TURIN   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c IRCCS   (Italy)

^d CTO HOSPITAL   (Italy)

^e IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^f MOLINETTE HOSPITAL   (Italy)

Author keywords

Neuropathic pain; Polyneuropathy; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; POLYNEUROPATHY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36; TREATMENT DURATION;

FEMALE; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; POLYNEUROPATHIES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 33746679149     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-006-0660-5     Document Type: Article

References (21)

1. Padua L, Schenone A, Aprile I et al (2005) Quality of life and disability assessment in neuropathy: A multicentre study. J Peripher Nerv Syst 10:3-10
2. Merkies IS, Schmitz PI, van der Meche FG et al Inflammatory Neuropathy Cause and Treatment (INCAT) group (2002) Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology 59:84-91
3. Galer BS, Gianas A, Jensen MP (1999) Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diab Res Clin Pract 47:123-128
4. Sommer C (2003) Painful neuropathies. Curr Opin Neurol 16:623-628
5. Nobile-Orazio E (2005) Treatment of dysimmune neuropathies. J Neurol 252:385-395
6. Dworkin RH, Backonja M, Rowbotham MC et al (2003) Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60:1524-1534
7. Chong MS, Bajwa ZH (2003) Diagnosis and treatment of neuropathic pain. J Pain Symptom Manage 25 [Suppl]:S4-S11
8. Cavaletti G, Jann S, Pace A et al (2006) Multicenter assessment of the total neuropathy score for chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst 11:135-141
9. Apolone G, Mosconi P (1998) The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51:1025-1036
10. De Benedittis G, Massei R, Nobili R, Pieri A (1988) The Italian Pain Questionnaire. Pain 33:53-62
11. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item shortform survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473-483
12. Melzack R (1975) The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1:271-299
13. Cornblath DR, Chaudhry V, Carter K et al (1999) Total neuropathy score: validation and reliability study. Neurology 53:1660-1664
14. Cruccu G, Anand P, Attal N et al (2004) EFNS guidelines on neuropathic pain assessment. Eur J Neurol 11:153-162
15. Schmader KE (2002) Epidemiology and impact on quality of life of post herpetic neuralgia and painful diabetic neuropathy. Clin J Pain 18:350-354
16. Simmons Z, Feldman EL (2002) Update on diabetic neuropathy. Curr Opin Neurol 15:595-603
17. Renaud S, Hays AP, Brannagan TH 3rd et al (2005) Gene expression profiling in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 159:203-214
18. Misra VP, Walker RW (2000) Acute-onset painful upper limb multifocal demyelinating motor neuropathy. J Neurol 247:949-954
19. Teunissen LL, Eurelings M, Notermans NC et al (2000) Quality of life in patients with axonal polyneuropathy. J Neurol 247:195-199
20. Pfeiffer G, Wicklein EM, Ratusinski T et al (2001) Disability and quality of life in Charcot-Marie-Tooth disease type I. J Neurol Neurosurg Psychiatry 70:548-550
21. Nobile-Orazio E, Meucci N, Baldini L et al (2000) Longterm prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain 123:710-717